McKesson

Cardinal Health

CMS Energy

Healthcare and Utilities Sectors Lead in Thursday Trading

卡地纳健康

Cardinal Health's 15min chart signals bearish trend with KDJ Death Cross, Bearish Marubozu.

Cardinal Health: Mizuho Keeps Outperform Rating, Raises PT to $235

Assessing Cardinal Health's Pricing Amidst Surge in Healthcare Supply Chain Role

Cardinal Health Triggers MACD and KDJ Death Crosses on 15-Minute Chart

Catalyst<ul> <li>Most analysts rate CAH Buy or Strong Buy, showing broad institutional optimism.</li> <li>Bullish signals are obviously dominant with three bullish technical indicators in recent data.</li></ul>Risk<ul> <li>Fund flow trends show negative overall net outflow, with large and extra-large orders trending out.</li> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough.</li></ul>

Key Factors

Cardinal Health (CAH) raised FY26 non-GAAP EPS guidance to $10.15-$10.35 following Q2 results showing 19% revenue growth to $65.6 billion and $750 million share repurchase. CAH shares surged 9.83% on February 5, 2026, hitting a 52-week high of $225.88, driven by strong Q2 fiscal 2026 earnings and revenue performance. Mizuho raised its price target for Cardinal Health (CAH) to $235 and maintained an outperform rating following the company's strong Q2 earnings and revised guidance.

Recent Updates

CAH News